World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
74
Citations
22275
World Ranking
1563
National Ranking
131

Overview

Robert C. Read is affiliated with the University of Southampton in the United Kingdom. Their research primarily focuses on Medicine, with significant contributions in the fields of Infectious Diseases, Epidemiology, Microbiology, Health, and Pulmonary and Respiratory Medicine.

Their work addresses numerous topics including SARS-CoV-2 and COVID-19 Research, Bacterial Infections and Vaccines, Pneumonia and Respiratory Infections, Vaccine Coverage and Hesitancy, COVID-19 Clinical Research Studies, Influenza Virus Research Studies, and Ethics in Clinical Research.

Robert C. Read has coauthored extensively with several frequent collaborators:

  • Saul N. Faust
  • Parvinder K. Aley
  • Yama F Mujadidi
  • Bassam Hallis
  • Teresa Lambe

Their publications are often found in a range of scientific journals, with repeated contributions in:

  • Journal of Infection
  • Current Opinion in Infectious Diseases
  • The Lancet
  • The Journal of Immunology
  • The Lancet Microbe

Among recent papers, notable works include:

  • Safety and immunogenicity of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine (Com-COV): a single-blind, randomised, non-inferiority trial (2021, The Lancet)
  • Safety, tolerability and viral kinetics during SARS-CoV-2 human challenge in young adults (2022, Nature Medicine)
  • Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): a blinded, multicentre, randomised, controlled, phase 2 trial (2021, Repository@Nottingham [University of Nottingham])
  • Immunogenicity, safety, and reactogenicity of heterologous COVID-19 primary vaccination incorporating mRNA, viral-vector, and protein-adjuvant vaccines in the UK (Com-COV2): a single-blind, randomised, phase 2, non-inferiority trial (2021, The Lancet)
  • Artificial intelligence, machine learning and deep learning: Potential resources for the infection clinician (2023, Journal of Infection)

Best Publications

  • BTS guidelines for the management of community acquired pneumonia in adults: update 2009.

    W S Lim;S V Baudouin;R C George;A T Hill

  • Guidelines for the management of adult lower respiratory tract infections ‐ Full version

    M. Woodhead;F. Blasi;S. Ewig;J. Garau

  • International ERS/ESICM/ESCMID/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia

    Antoni Torres;Michael S Niederman;Jean Chastre;Santiago Ewig

  • ESCMID guideline: diagnosis and treatment of acute bacterial meningitis.

    D van de Beek;C Cabellos;O Dzupova;S Esposito

  • Guidelines for the management of adult lower respiratory tract infections - Summary

    M. Woodhead;F. Blasi;S. Ewig;J. Garau

  • Safety and immunogenicity of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine (Com-COV): a single-blind, randomised, non-inferiority trial.

    Xinxue Liu;Robert H Shaw;Arabella S V Stuart;Melanie Greenland

  • Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): a blinded, multicentre, randomised, controlled, phase 2 trial

    Alasdair P S Munro;Alasdair P S Munro;Leila Janani;Victoria Cornelius;Parvinder K Aley

  • Effects of human neutrophil elastase and Pseudomonas aeruginosa proteinases on human respiratory epithelium.

    Ryoichi Amitani;Robert Wilson;Andrew Rutman;Robert Read

  • Methylation status of a single CpG site in the IL6 promoter is related to IL6 messenger RNA levels and rheumatoid arthritis

    Christoper J. Nile;Robert C. Read;Mohammed Akil;Gordon W. Duff

  • Immunogenicity, safety, and reactogenicity of heterologous COVID-19 primary vaccination incorporating mRNA, viral-vector, and protein-adjuvant vaccines in the UK (Com-COV2): a single-blind, randomised, phase 2, non-inferiority trial

    Unknown

  • Macrophage defences against respiratory tract infections.

    S B Gordon;R C Read

  • Risk factors for hospitalisation and poor outcome with pandemic A/H1N1 influenza: United Kingdom first wave (May-September 2009).

    J S Nguyen-Van-Tam;P J M Openshaw;A Hashim;E M Gadd

  • Toll-Like Receptors in Health and Disease: Complex Questions Remain

    Ian Sabroe;Robert C. Read;Moira K. B. Whyte;David H. Dockrell

  • Effect of a quadrivalent meningococcal ACWY glycoconjugate or a serogroup B meningococcal vaccine on meningococcal carriage: an observer-blind, phase 3 randomised clinical trial

    Robert C Read;David Baxter;David R Chadwick;Saul N Faust;Saul N Faust

  • von Willebrand factor is an acute phase reactant in man

    B.E. Pottinger;R.C. Read;E.M. Paleolog;P.G. Higgins

  • The UK joint specialist societies guideline on the diagnosis and management of acute meningitis and meningococcal sepsis in immunocompetent adults

    F McGill;R S Heyderman;B D Michael;B D Michael;S Defres;S Defres;S Defres

  • Identification of In Vivo–Expressed Antigens of Staphylococcus aureus and Their Use in Vaccinations for Protection against Nasal Carriage

    Simon R. Clarke;Kirsten J. Brummell;Malcolm J. Horsburgh;Philip W. McDowell

  • Effective nasal influenza vaccine delivery using chitosan.

    Robert C. Read;Simone C. Naylor;Christopher W. Potter;Jenny Bond

  • A Functional Polymorphism of Toll-like Receptor 4 Is Not Associated with Likelihood or Severity of Meningococcal Disease

    Robert C. Read;Jodie Pullin;Simone Gregory;Raymond Borrow

  • Mannose-Binding Lectin Regulates the Inflammatory Response of Human Professional Phagocytes to Neisseria meningitidis Serogroup B

    Dominic L. Jack;Robert C. Read;Andrea J. Tenner;Matthias Frosch

  • A lipopolysaccharide-deficient mutant of Neisseria meningitidis elicits attenuated cytokine release by human macrophages and signals via toll-like receptor (TLR) 2 but not via TLR4/MD2.

    Alison C. Pridmore;David H. Wyllie;Fatumo Abdillahi;Liana Steeghs

  • Interaction of Nontypable Haemophilus influenzae with Human Respiratory Mucosa In Vitro

    Robert C. Read;Robert Wilson;Andrew Rutman;Valerie Lund

  • Flavohemoglobin Hmp protects Salmonella enterica serovar typhimurium from nitric oxide-related killing by human macrophages.

    Tânia M. Stevanin;Robert K. Poole;Eric A. G. Demoncheaux;Robert C. Read

Frequent Co-Authors

Stephen B. Gordon
Stephen B. Gordon Liverpool School of Tropical Medicine
David H. Dockrell
David H. Dockrell University of Edinburgh
Ray Borrow
Ray Borrow Manchester Royal Infirmary
Jonathan S. Nguyen-Van-Tam
Jonathan S. Nguyen-Van-Tam University of Nottingham
Karl G. Nicholson
Karl G. Nicholson University of Leicester
Malcolm E. Molyneux
Malcolm E. Molyneux Liverpool School of Tropical Medicine
Peter J. M. Openshaw
Peter J. M. Openshaw Imperial College London
Saul N. Faust
Saul N. Faust University Hospital Southampton NHS Foundation Trust
Nima Rezaei
Nima Rezaei Tehran University of Medical Sciences
Moira K. B. Whyte
Moira K. B. Whyte University of Edinburgh

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring online degrees related to Microbiology can open doors to diverse career pathways beyond traditional lab work. For those with unique challenges, finding the best associate degrees for felons offers valuable opportunities to advance in the healthcare and science fields, including microbiology-related roles.

One promising path is becoming a Functional Medicine Nurse Practitioner, which combines a deep understanding of biology with patient care. You can learn more about the requirements and benefits of this role by checking out the guide on functional medicine NP careers.

For those interested in the administrative side of healthcare, becoming a Certified Professional Coder is a valuable option. This certification ensures expertise in medical coding, an essential skill in healthcare documentation, with competitive compensation. Details about earning potential and career growth can be found in the section on cpc medical coding salary.

Similarly, pursuing a role as a Health Information Manager merges organizational skills with healthcare knowledge. Entry-level salaries and career pathways are outlined in the informative article on health information management salary entry-level, which can help guide your decision-making process.

Best Scientists Citing Robert C. Read

Trending Scientists